Tirzepatide is a dual-action medication known as a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
When paired with semaglutide , which targets GLP-1 receptors, the result is a complementary pathway approach , tapping into both incretin and amylin networks for broader metabolic control
Mentorship-style insight from 20 years of real-world practice building confidence, refining technique, and developing the clinical judgement that separates good practitioners from exceptional ones
BPC-157 is a synthetic pentadecapeptide derived from human gastric BPC protein
Peptides occur naturally in the body (endogenous) but can also be administered externally (exogenous)
Cagrilintide remains an investigational research peptide intended for laboratory and scientific research purposes and continues to be studied across multiple areas of metabolic health and energy regulation research